BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 28747380)

  • 1. Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify.
    Komor MA; Pham TV; Hiemstra AC; Piersma SR; Bolijn AS; Schelfhorst T; Delis-van Diemen PM; Tijssen M; Sebra RP; Ashby M; Meijer GA; Jimenez CR; Fijneman RJA
    Mol Cell Proteomics; 2017 Oct; 16(10):1850-1863. PubMed ID: 28747380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ProteomeGenerator: A Framework for Comprehensive Proteomics Based on de Novo Transcriptome Assembly and High-Accuracy Peptide Mass Spectral Matching.
    Cifani P; Dhabaria A; Chen Z; Yoshimi A; Kawaler E; Abdel-Wahab O; Poirier JT; Kentsis A
    J Proteome Res; 2018 Nov; 17(11):3681-3692. PubMed ID: 30295032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ASV-ID, a Proteogenomic Workflow To Predict Candidate Protein Isoforms on the Basis of Transcript Evidence.
    Jeong SK; Kim CY; Paik YK
    J Proteome Res; 2018 Dec; 17(12):4235-4242. PubMed ID: 30289715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Read-Split-Run: an improved bioinformatics pipeline for identification of genome-wide non-canonical spliced regions using RNA-Seq data.
    Bai Y; Kinne J; Donham B; Jiang F; Ding L; Hassler JR; Kaufman RJ
    BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):503. PubMed ID: 27556805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PASS: A Proteomics Alternative Splicing Screening Pipeline.
    Wu P; Pu L; Deng B; Li Y; Chen Z; Liu W
    Proteomics; 2019 Jul; 19(13):e1900041. PubMed ID: 31095856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of SF3B1 inhibits cell proliferation, invasion and migration triggering apoptosis in breast cancer via aberrant splicing.
    Zhang L; Zhang X; Zhang H; Liu F; Bi Y; Zhang Y; Cheng C; Liu J
    Breast Cancer; 2020 May; 27(3):464-476. PubMed ID: 31919642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel alternative splicing biomarkers for breast cancer with LC/MS/MS and RNA-Seq.
    Zhang F; Deng CK; Wang M; Deng B; Barber R; Huang G
    BMC Bioinformatics; 2020 Dec; 21(Suppl 9):541. PubMed ID: 33272210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced protein isoform characterization through long-read proteogenomics.
    Miller RM; Jordan BT; Mehlferber MM; Jeffery ED; Chatzipantsiou C; Kaur S; Millikin RJ; Dai Y; Tiberi S; Castaldi PJ; Shortreed MR; Luckey CJ; Conesa A; Smith LM; Deslattes Mays A; Sheynkman GM
    Genome Biol; 2022 Mar; 23(1):69. PubMed ID: 35241129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteogenomic analysis reveals alternative splicing and translation as part of the abscisic acid response in Arabidopsis seedlings.
    Zhu FY; Chen MX; Ye NH; Shi L; Ma KL; Yang JF; Cao YY; Zhang Y; Yoshida T; Fernie AR; Fan GY; Wen B; Zhou R; Liu TY; Fan T; Gao B; Zhang D; Hao GF; Xiao S; Liu YG; Zhang J
    Plant J; 2017 Aug; 91(3):518-533. PubMed ID: 28407323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant splicing isoforms detected by full-length transcriptome sequencing as transcripts of potential neoantigens in non-small cell lung cancer.
    Oka M; Xu L; Suzuki T; Yoshikawa T; Sakamoto H; Uemura H; Yoshizawa AC; Suzuki Y; Nakatsura T; Ishihama Y; Suzuki A; Seki M
    Genome Biol; 2021 Jan; 22(1):9. PubMed ID: 33397462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteogenomic, Epigenetic, and Clinical Implications of Recurrent Aberrant Splice Variants in Clear Cell Renal Cell Carcinoma.
    Chang A; Chakiryan NH; Du D; Stewart PA; Zhang Y; Tian Y; Soupir AC; Bowers K; Fang B; Morganti A; Teer JK; Kim Y; Spiess PE; Chahoud J; Noble JD; Putney RM; Berglund AE; Robinson TJ; Koomen JM; Wang L; Manley BJ
    Eur Urol; 2022 Oct; 82(4):354-362. PubMed ID: 35718636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Jerantinine A induces tumor-specific cell death through modulation of splicing factor 3b subunit 1 (SF3B1).
    Chung FF; Tan PF; Raja VJ; Tan BS; Lim KH; Kam TS; Hii LW; Tan SH; See SJ; Tan YF; Wong LZ; Yam WK; Mai CW; Bradshaw TD; Leong CO
    Sci Rep; 2017 Feb; 7():42504. PubMed ID: 28198434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Next Generation Sequencing Data and Proteogenomics.
    Ruggles KV; Fenyö D
    Adv Exp Med Biol; 2016; 926():11-19. PubMed ID: 27686803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Splicing Factor 3b Subunit 1 (SF3B1) Reduced Cell Proliferation, Induced Apoptosis and Resulted in Cell Cycle Arrest by Regulating Homeobox A10 (HOXA10) Splicing in AGS and MKN28 Human Gastric Cancer Cells.
    Zhang Y; Yuan Z; Jiang Y; Shen R; Gu M; Xu W; Gu X
    Med Sci Monit; 2020 Jan; 26():e919460. PubMed ID: 31927557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the aberrant splicing of MAP3K7 induced by cancer-associated SF3B1 mutation.
    Li Z; Zhao B; Shi Y; Liang Y; Qian R; Wan Y
    J Biochem; 2021 Sep; 170(1):69-77. PubMed ID: 33751071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splicing factor SF3B1 promotes endometrial cancer progression via regulating KSR2 RNA maturation.
    Popli P; Richters MM; Chadchan SB; Kim TH; Tycksen E; Griffith O; Thaker PH; Griffith M; Kommagani R
    Cell Death Dis; 2020 Oct; 11(10):842. PubMed ID: 33040078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical presentation and differential splicing of SRSF2, U2AF1 and SF3B1 mutations in patients with acute myeloid leukemia.
    Bamopoulos SA; Batcha AMN; Jurinovic V; Rothenberg-Thurley M; Janke H; Ksienzyk B; Philippou-Massier J; Graf A; Krebs S; Blum H; Schneider S; Konstandin N; Sauerland MC; Görlich D; Berdel WE; Woermann BJ; Bohlander SK; Canzar S; Mansmann U; Hiddemann W; Braess J; Spiekermann K; Metzeler KH; Herold T
    Leukemia; 2020 Oct; 34(10):2621-2634. PubMed ID: 32358566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Alternative Splicing in Proteomes of Human Melanoma Cell Lines without RNA Sequencing Data.
    Lobas AA; Solovyeva EM; Levitsky LI; Goncharov AO; Lyssuk EY; Larin SS; Moshkovskii SA; Gorshkov MV
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of SF3B1 by molecules targeting the spliceosome results in massive aberrant exon skipping.
    Wu G; Fan L; Edmonson MN; Shaw T; Boggs K; Easton J; Rusch MC; Webb TR; Zhang J; Potter PM
    RNA; 2018 Aug; 24(8):1056-1066. PubMed ID: 29844105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Full-length transcript characterization of SF3B1 mutation in chronic lymphocytic leukemia reveals downregulation of retained introns.
    Tang AD; Soulette CM; van Baren MJ; Hart K; Hrabeta-Robinson E; Wu CJ; Brooks AN
    Nat Commun; 2020 Mar; 11(1):1438. PubMed ID: 32188845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.